Stallard N - Search Results

1

Recent advances in methodology for clinical trials in small populations: the InSPiRe project.

Friede T, Posch M, Zohar S, Alberti C, Benda N, Comets E, Day S, Dmitrienko A, Graf A, Günhan BK, Hee SW, Lentz F, Madan J, Miller F, Ondra T, Pearce M, Röver C, Toumazi A, Unkel S, Ursino M, Wassmer G, Stallard N. Friede T, et al. Among authors: stallard n. Orphanet J Rare Dis. 2018 Oct 25;13(1):186. doi: 10.1186/s13023-018-0919-y. Orphanet J Rare Dis. 2018. PMID: 30359266 Free PMC article. Review.

2

A group-sequential design for clinical trials with treatment selection.

Stallard N, Friede T. Stallard N, et al. Stat Med. 2008 Dec 20;27(29):6209-27. doi: 10.1002/sim.3436. Stat Med. 2008. PMID: 18792085

3

A comparison of methods for adaptive treatment selection.

Friede T, Stallard N. Friede T, et al. Among authors: stallard n. Biom J. 2008 Oct;50(5):767-81. doi: 10.1002/bimj.200710453. Biom J. 2008. PMID: 18932136

4

Optimal choice of the number of treatments to be included in a clinical trial.

Stallard N, Posch M, Friede T, Koenig F, Brannath W. Stallard N, et al. Stat Med. 2009 Apr 30;28(9):1321-38. doi: 10.1002/sim.3551. Stat Med. 2009. PMID: 19243083

5

A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.

Chataway J, Nicholas R, Todd S, Miller DH, Parsons N, Valdés-Márquez E, Stallard N, Friede T. Chataway J, et al. Among authors: stallard n. Mult Scler. 2011 Jan;17(1):81-8. doi: 10.1177/1352458510382129. Epub 2010 Aug 26. Mult Scler. 2011. PMID: 20798135

6

Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug Administration.

Brannath W, Burger HU, Glimm E, Stallard N, Vandemeulebroecke M, Wassmer G. Brannath W, et al. Among authors: stallard n. J Biopharm Stat. 2010 Nov;20(6):1125-31. doi: 10.1080/10543406.2010.514453. J Biopharm Stat. 2010. PMID: 21058108

7

Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis.

Friede T, Parsons N, Stallard N, Todd S, Valdes Marquez E, Chataway J, Nicholas R. Friede T, et al. Among authors: stallard n. Stat Med. 2011 Jun 15;30(13):1528-40. doi: 10.1002/sim.4202. Epub 2011 Feb 22. Stat Med. 2011. PMID: 21341301

8

Group-sequential methods for adaptive seamless phase II/III clinical trials.

Stallard N. Stallard N. J Biopharm Stat. 2011 Jul;21(4):787-801. doi: 10.1080/10543406.2011.551335. J Biopharm Stat. 2011. PMID: 21516569 Review.

9

Optimal sample sizes for phase II clinical trials and pilot studies.

Stallard N. Stallard N. Stat Med. 2012 May 20;31(11-12):1031-42. doi: 10.1002/sim.4357. Epub 2011 Nov 3. Stat Med. 2012. PMID: 22052407

10

A hybrid procedure for detecting global treatment effects in multivariate clinical trials: theory and applications to fMRI studies.

Minas G, Rigat F, Nichols TE, Aston JA, Stallard N. Minas G, et al. Among authors: stallard n. Stat Med. 2012 Feb 10;31(3):253-68. doi: 10.1002/sim.4395. Epub 2011 Dec 15. Stat Med. 2012. PMID: 22170084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters